Delivery Order SPE2DB20D2001-SPE2DB23FM37W
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 36,000 units of Creon DR 100 capsules. The $5,661.34 firm fixed-price delivery order has a completion date of March 7, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of 36,000 units of Creon DR 100s capsules to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $5,649.84 and a completion date of December 22, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,635.08, is a delivery order for the supply of 24,000 units of Creon DR 100 capsules. The contract has a completion date of September 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 24,000 unit capsules of the medication CREON DR. The $5,323.90 fixed-price contract has a completion date of May 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,861.74 firm-fixed-price delivery order is for the delivery of 24,000 units of CREON DR 100-count capsules. The contract has a completion date of May 7, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 24,000 units of Creon DR 100s capsules. The $1,225.41 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc. This IDC serves as a primary vehicle for Cencora to supply a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,192.39 firm fixed-price delivery order is for 36,000 units of the pharmaceutical product CREON DR 36,000 UNIT CAPSULE 100S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract, valued at $15,821.94, is for the delivery of 24,000 units of the pharmaceutical product CREON DR 100S capsules. The contract is a firm fixed-price delivery order with a completion date of May 16, 2023. This award is not part of a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,752.44 delivery order contract is for the supply of 36,000 units of the drug CREON DR 100S capsule. The contract is a firm fixed-price delivery order that runs through October 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has received numerous DLA contract awards to supply a wide range of medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,542.73 firm fixed-price delivery order is for 24,000 units of the medication CREON DR 100S capsules. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM37WDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 36,000 units of Creon DR 100s capsules. The $7,102.97 firm fixed-price contract has a completion date of January 25, 2023, and is an open competition award with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 1/24/23 |